Global Spinal Muscular Atrophy Medicine Market Growth 2023-2029

Global Spinal Muscular Atrophy Medicine Market Growth 2023-2029

LPI (LP Information)' newest research report, the “Spinal Muscular Atrophy Medicine Industry Forecast” looks at past sales and reviews total world Spinal Muscular Atrophy Medicine sales in 2022, providing a comprehensive analysis by region and market sector of projected Spinal Muscular Atrophy Medicine sales for 2023 through 2029. With Spinal Muscular Atrophy Medicine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Spinal Muscular Atrophy Medicine industry.

This Insight Report provides a comprehensive analysis of the global Spinal Muscular Atrophy Medicine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Spinal Muscular Atrophy Medicine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Spinal Muscular Atrophy Medicine market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Spinal Muscular Atrophy Medicine and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Spinal Muscular Atrophy Medicine.

The global Spinal Muscular Atrophy Medicine market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Spinal Muscular Atrophy Medicine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Spinal Muscular Atrophy Medicine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Spinal Muscular Atrophy Medicine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Spinal Muscular Atrophy Medicine players cover Astellas Pharma Inc., AveXis, Inc., Bioblast Pharma Ltd., Cytokinetics, Inc. 24, F. Hoffmann-La Roche Ltd., Genethon, Genzyme Corporation, GMP-Orphan SAS and Ionis Pharmaceuticals, Inc., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Spinal Muscular Atrophy Medicine market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type
LMI-070
ND-602
NT-1654
Nusinersen
NXD-30001
Others

Segmentation by application
Hospital
Clinic
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Astellas Pharma Inc.
AveXis, Inc.
Bioblast Pharma Ltd.
Cytokinetics, Inc. 24
F. Hoffmann-La Roche Ltd.
Genethon
Genzyme Corporation
GMP-Orphan SAS
Ionis Pharmaceuticals, Inc.
Longevity Biotech, Inc
Neurodyn Inc.
Neurotune AG
Novartis AG
Sarepta Therapeutics, Inc.
Voyager Therapeutics, Inc.
Vybion, Inc.
WAVE Life Sciences Ltd.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Spinal Muscular Atrophy Medicine market?

What factors are driving Spinal Muscular Atrophy Medicine market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Spinal Muscular Atrophy Medicine market opportunities vary by end market size?

How does Spinal Muscular Atrophy Medicine break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?

Please note: The report will take approximately 2 business days to prepare and deliver.